1. Home
  2. MPU vs SCLX Comparison

MPU vs SCLX Comparison

Compare MPU & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MPU

Mega Matrix Corp.

HOLD

Current Price

$0.73

Market Cap

44.8M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.30

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPU
SCLX
Founded
1989
2011
Country
Singapore
United States
Employees
N/A
30
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8M
52.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MPU
SCLX
Price
$0.73
$6.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.1K
34.0K
Earning Date
03-09-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$3.60
52 Week High
$4.44
$34.27

Technical Indicators

Market Signals
Indicator
MPU
SCLX
Relative Strength Index (RSI) 43.58 37.41
Support Level $0.72 $6.20
Resistance Level $0.81 $7.76
Average True Range (ATR) 0.04 0.67
MACD -0.00 -0.02
Stochastic Oscillator 53.54 56.46

Price Performance

Historical Comparison
MPU
SCLX

About MPU Mega Matrix Corp.

Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: